Fimmic invites ECDP 2018 participants to attend our pre-conference symposium on Tuesday May 29, 2-4 PM at Hotel Clarion in Helsinki, Finland. The first part of our 2-hour symposium will feature customer presenters discussing how they are...

Another day, another day of pathology artificial intelligence (AI) news. This recently from Proscia in partnership with Proteocyte AI. Proscia Inc., creators of AI-powered digital pathology software, and Proteocyte AI, a company designing...

Webinar: Why Healthcare’s Accelerating Transformation is Both Threat and Potential for Anatomic Pathologists: A Candid Look at Eroding Group Practice Finances, Unwelcome Payer Trends, Clinical Opportunities, and the Promise of Genetic...

In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help...

A pair of recently developed AI systems can diagnose lung cancer and heart disease more accurately than human doctors. These AIs have the potential to save billions of dollars and countless lives if widely adopted. Improved...

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial...